US5795714A
(en)
*
|
1992-11-06 |
1998-08-18 |
Trustees Of Boston University |
Method for replicating an array of nucleic acid probes
|
US6436635B1
(en)
*
|
1992-11-06 |
2002-08-20 |
Boston University |
Solid phase sequencing of double-stranded nucleic acids
|
EP1262564A3
(de)
|
1993-01-07 |
2004-03-31 |
Sequenom, Inc. |
Dns-Sequenzierung durch Massenspektrometrie
|
US5605798A
(en)
|
1993-01-07 |
1997-02-25 |
Sequenom, Inc. |
DNA diagnostic based on mass spectrometry
|
US6194144B1
(en)
|
1993-01-07 |
2001-02-27 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry
|
FR2703693B1
(fr)
*
|
1993-04-06 |
1995-07-13 |
Pasteur Institut |
Procédé rapide de détermination d'une séquence d'ADN et application au séquençage et au diagnostic.
|
NZ267842A
(en)
*
|
1993-05-28 |
1997-09-22 |
Baylor College Medicine |
Apparatus for measuring molecular mass (by mass spectrometry) in which the sample is ionised on the sample holder and desorbed therefrom by laser pulses
|
US6020208A
(en)
*
|
1994-05-27 |
2000-02-01 |
Baylor College Of Medicine |
Systems for surface-enhanced affinity capture for desorption and detection of analytes
|
US20020037517A1
(en)
*
|
1993-05-28 |
2002-03-28 |
Hutchens T. William |
Methods for sequencing biopolymers
|
JPH09505397A
(ja)
*
|
1993-11-17 |
1997-05-27 |
アマーシャム・インターナショナル・ピーエルシー |
プライマー伸長質量分光分析による核酸配列決定法
|
SI9400107A
(en)
|
1994-03-02 |
1995-10-31 |
Lek Tovarna Farmacevtskih |
New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
|
JPH09511507A
(ja)
*
|
1994-04-04 |
1997-11-18 |
フリーマン,ウイリアム・アール |
上昇した眼圧を治療するためのホスホニルメトキシアルキルヌクレオシドの使用
|
CA2204378C
(en)
*
|
1994-11-07 |
2007-05-08 |
Yoshihide Hayashizaki |
Method for determining dna nucleotide sequence
|
GB9504598D0
(en)
*
|
1995-03-03 |
1995-04-26 |
Imp Cancer Res Tech |
Method of nucleic acid analysis
|
SI9500074A
(en)
*
|
1995-03-10 |
1996-10-31 |
Lek Tovarna Farmacevtskih |
Process for preparation of alkani salts of clavulanic acid.
|
AU769545B2
(en)
*
|
1995-03-17 |
2004-01-29 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
US6428955B1
(en)
|
1995-03-17 |
2002-08-06 |
Sequenom, Inc. |
DNA diagnostics based on mass spectrometry
|
JPH11503611A
(ja)
*
|
1995-04-11 |
1999-03-30 |
トラスティーズ・オブ・ボストン・ユニバーシティ |
生体高分子の固相配列決定法
|
US7803529B1
(en)
*
|
1995-04-11 |
2010-09-28 |
Sequenom, Inc. |
Solid phase sequencing of biopolymers
|
US20060063193A1
(en)
*
|
1995-04-11 |
2006-03-23 |
Dong-Jing Fu |
Solid phase sequencing of double-stranded nucleic acids
|
US5750341A
(en)
*
|
1995-04-17 |
1998-05-12 |
Lynx Therapeutics, Inc. |
DNA sequencing by parallel oligonucleotide extensions
|
US5700642A
(en)
*
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
US5830655A
(en)
|
1995-05-22 |
1998-11-03 |
Sri International |
Oligonucleotide sizing using cleavable primers
|
US6146854A
(en)
*
|
1995-08-31 |
2000-11-14 |
Sequenom, Inc. |
Filtration processes, kits and devices for isolating plasmids
|
US6432716B2
(en)
*
|
1995-10-03 |
2002-08-13 |
The Penn State Research Foundation |
Method to identify a surface-bound molecule
|
DE19543065C2
(de)
*
|
1995-11-09 |
2002-10-31 |
Gag Bioscience Gmbh Zentrum Fu |
Verfahren zur Genomanalyse und Mittel zur Durchführung des Verfahrens
|
KR100482915B1
(ko)
*
|
1996-01-23 |
2005-09-12 |
퀴아진 지노믹스, 인코포레이티드 |
크기기술을사용하여핵산분자를분석하기위한방법및조성물
|
US6613508B1
(en)
|
1996-01-23 |
2003-09-02 |
Qiagen Genomics, Inc. |
Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
|
CZ218498A3
(cs)
*
|
1996-01-23 |
1998-12-16 |
Rapigene, Inc. |
Způsoby a kompozice pro stanovení sekvence molekul nukleových kyselin
|
EP0992511B1
(de)
*
|
1996-01-23 |
2009-03-11 |
Operon Biotechnologies, Inc. |
Verfahren und Zusammensetzungen zur Bestimmung von Sequenzen von Nukleinsäure-Molekülen
|
US6027890A
(en)
*
|
1996-01-23 |
2000-02-22 |
Rapigene, Inc. |
Methods and compositions for enhancing sensitivity in the analysis of biological-based assays
|
US6312893B1
(en)
|
1996-01-23 |
2001-11-06 |
Qiagen Genomics, Inc. |
Methods and compositions for determining the sequence of nucleic acid molecules
|
US6051378A
(en)
*
|
1996-03-04 |
2000-04-18 |
Genetrace Systems Inc. |
Methods of screening nucleic acids using mass spectrometry
|
WO1997037041A2
(en)
*
|
1996-03-18 |
1997-10-09 |
Sequenom, Inc. |
Dna sequencing by mass spectrometry
|
EP0898575B1
(de)
|
1996-04-17 |
2004-12-29 |
KÖSTER, Hubert, Dr. |
Kombinatorische schutzgruppestrategie für multifunktionelle molekule
|
US5928906A
(en)
*
|
1996-05-09 |
1999-07-27 |
Sequenom, Inc. |
Process for direct sequencing during template amplification
|
US6022688A
(en)
|
1996-05-13 |
2000-02-08 |
Sequenom, Inc. |
Method for dissociating biotin complexes
|
US5780232A
(en)
*
|
1996-05-28 |
1998-07-14 |
Atom Sciences, Inc. |
DNA sequencing, mapping, and diagnostic processes using hybridization and stable isotope labels of DNA
|
DE19629281A1
(de)
*
|
1996-07-19 |
1998-01-29 |
Bruker Franzen Analytik Gmbh |
Verfahren zur Vorbereitung von Biomaterialproben für die massenspektrometrische Analyse von Genmerkmalen
|
DE19629543C2
(de)
*
|
1996-07-22 |
1999-02-11 |
Immuno Ag |
Immunassay zum Nachweis von anti-B. burgdorferi Antikörpern und Verfahren zur Serodiagnose bei Lyme Borreliose, diagnostische Mittel und Testkits zur Durchführung der Verfahren
|
US5821060A
(en)
*
|
1996-08-02 |
1998-10-13 |
Atom Sciences, Inc. |
DNA sequencing, mapping, and diagnostic processes using hybridization chips and unlabeled DNA
|
US5902879A
(en)
*
|
1996-08-05 |
1999-05-11 |
Fidelity Systems, Inc. |
Methoxyoxalamido and succinimido precursors for nucleophilic addition to nucleosides, nucleotides and oligonucleotides
|
WO1998012355A1
(en)
*
|
1996-09-19 |
1998-03-26 |
Genetrace Systems |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5965363A
(en)
*
|
1996-09-19 |
1999-10-12 |
Genetrace Systems Inc. |
Methods of preparing nucleic acids for mass spectrometric analysis
|
US5777324A
(en)
|
1996-09-19 |
1998-07-07 |
Sequenom, Inc. |
Method and apparatus for maldi analysis
|
US5885775A
(en)
*
|
1996-10-04 |
1999-03-23 |
Perseptive Biosystems, Inc. |
Methods for determining sequences information in polynucleotides using mass spectrometry
|
US6133436A
(en)
*
|
1996-11-06 |
2000-10-17 |
Sequenom, Inc. |
Beads bound to a solid support and to nucleic acids
|
US6024925A
(en)
|
1997-01-23 |
2000-02-15 |
Sequenom, Inc. |
Systems and methods for preparing low volume analyte array elements
|
US6140053A
(en)
*
|
1996-11-06 |
2000-10-31 |
Sequenom, Inc. |
DNA sequencing by mass spectrometry via exonuclease degradation
|
ATE259056T1
(de)
*
|
1996-11-06 |
2004-02-15 |
Sequenom Inc |
Verfahren zur massenspektrometrie
|
CA2270132A1
(en)
*
|
1996-11-06 |
1998-05-14 |
Sequenom, Inc. |
Dna diagnostics based on mass spectrometry
|
US7285422B1
(en)
*
|
1997-01-23 |
2007-10-23 |
Sequenom, Inc. |
Systems and methods for preparing and analyzing low volume analyte array elements
|
US6110676A
(en)
*
|
1996-12-04 |
2000-08-29 |
Boston Probes, Inc. |
Methods for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
JP2001524808A
(ja)
|
1996-12-10 |
2001-12-04 |
ジーントレイス・システムズ・インコーポレイテッド |
放出可能な不揮発性の質量標識分子
|
US6699668B1
(en)
|
1997-01-15 |
2004-03-02 |
Xzillion Gmbh & Co. |
Mass label linked hybridisation probes
|
CN100434531C
(zh)
*
|
1997-01-15 |
2008-11-19 |
X齐里昂有限两合公司 |
与质量标记连接的杂交探针
|
WO1998033808A2
(en)
*
|
1997-02-04 |
1998-08-06 |
Hubert Koster |
A reversible stoichiometric process for conjugating biomolecules
|
DE69825601T2
(de)
|
1997-02-12 |
2005-04-28 |
Chan, Eugene Y, Brookline |
Verfahren zur analyse von polymeren
|
US6524795B1
(en)
|
1997-03-10 |
2003-02-25 |
Interleukin Genetics, Inc. |
Diagnostics for cardiovascular disorders
|
DE19710166C1
(de)
*
|
1997-03-12 |
1998-12-10 |
Bruker Franzen Analytik Gmbh |
Zwei-Schritt-Verfahren der DNA-Amplifikation für MALDI-TOF-Messungen
|
US6235471B1
(en)
|
1997-04-04 |
2001-05-22 |
Caliper Technologies Corp. |
Closed-loop biochemical analyzers
|
US6391622B1
(en)
|
1997-04-04 |
2002-05-21 |
Caliper Technologies Corp. |
Closed-loop biochemical analyzers
|
JP2001521622A
(ja)
*
|
1997-04-04 |
2001-11-06 |
カリパー テクノロジーズ コーポレイション |
閉ループ生化学分析器
|
DE69842225D1
(de)
|
1997-04-16 |
2011-05-26 |
Millennium Pharm Inc |
Zusammensetzung, umfassend einen Antikörper, der selektiv an ein cysteinreiches sekretiertes Protein (CRSP) bindet
|
WO1998053296A1
(en)
*
|
1997-05-19 |
1998-11-26 |
Charles Evans And Associates |
Analysis of molecules bound to solid surfaces using selective bond cleavage processes
|
GB9710582D0
(en)
|
1997-05-22 |
1997-07-16 |
Oxford Glycosciences Uk Ltd |
A method for de novo peptide sequence determination
|
US6426411B1
(en)
|
1997-05-30 |
2002-07-30 |
Dana-Farber Cancer Institute |
PGC-1, a novel brown fat pparγ coactivator
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
WO1999000657A1
(en)
*
|
1997-06-26 |
1999-01-07 |
Perseptive Biosystems, Inc. |
High density sample holder for analysis of biological samples
|
US6482938B1
(en)
*
|
1997-07-11 |
2002-11-19 |
Wako Pure Chemical Industries, Ltd. |
Compounds having energy transfer function and method for DNA base sequencing by using the same
|
EP1002128A1
(de)
*
|
1997-07-11 |
2000-05-24 |
Brax Genomics Limited |
Charakterisierung von nukleinsäuren
|
US6312904B1
(en)
*
|
1997-07-11 |
2001-11-06 |
Xzillion Gmbh & Co. Kg |
Characterizing nucleic acid
|
JP2001511362A
(ja)
*
|
1997-07-22 |
2001-08-14 |
ラピジーン,インコーポレイテッド |
Msにより配列決定データを相関させるコンピュータ方法およびシステム
|
CA2297661A1
(en)
*
|
1997-07-22 |
1999-02-04 |
Darwin Molecular Corp. |
Amplification and other enzymatic reactions performed on nucleic acid arrays
|
ATE240408T1
(de)
*
|
1997-07-22 |
2003-05-15 |
Qiagen Genomics Inc |
Verfahren und verbindungen zur analysierung von nukleinsaeuren durch massenspektrometrie
|
US6207370B1
(en)
|
1997-09-02 |
2001-03-27 |
Sequenom, Inc. |
Diagnostics based on mass spectrometric detection of translated target polypeptides
|
GB9718921D0
(en)
*
|
1997-09-05 |
1997-11-12 |
Brax Genomics Ltd |
Catalytically generated mass labels
|
US20110166040A1
(en)
*
|
1997-09-05 |
2011-07-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of e. coli o157:h7
|
WO1999014362A1
(en)
*
|
1997-09-15 |
1999-03-25 |
Brax Group Limited |
Characterising nucleic acid by mass spectrometry
|
US6090558A
(en)
*
|
1997-09-19 |
2000-07-18 |
Genetrace Systems, Inc. |
DNA typing by mass spectrometry with polymorphic DNA repeat markers
|
US6764822B1
(en)
|
1997-09-19 |
2004-07-20 |
Sequenom, Inc. |
DNA typing by mass spectrometry with polymorphic DNA repeat markers
|
US6962778B1
(en)
|
1997-09-25 |
2005-11-08 |
Boston Probes, Inc. |
Methods, kits and compositions for suppressing the binding of detectable probes to non-target sequences in hybridization assays
|
US6617438B1
(en)
|
1997-11-05 |
2003-09-09 |
Sirna Therapeutics, Inc. |
Oligoribonucleotides with enzymatic activity
|
US6127535A
(en)
*
|
1997-11-05 |
2000-10-03 |
Ribozyme Pharmaceuticals, Inc. |
Nucleoside triphosphates and their incorporation into oligonucleotides
|
US6322968B1
(en)
|
1997-11-21 |
2001-11-27 |
Orchid Biosciences, Inc. |
De novo or “universal” sequencing array
|
FR2771422B1
(fr)
*
|
1997-11-21 |
2001-07-27 |
Centre Nat Rech Scient |
Reactifs et methodes pour la detection de genes lies au complexe majeur d'histocompatibilite d'oiseaux d'elevage, tels que le poulet
|
US6268131B1
(en)
|
1997-12-15 |
2001-07-31 |
Sequenom, Inc. |
Mass spectrometric methods for sequencing nucleic acids
|
US6562567B2
(en)
|
1998-01-27 |
2003-05-13 |
California Institute Of Technology |
Method of detecting a nucleic acid
|
US6407816B1
(en)
*
|
1998-02-23 |
2002-06-18 |
Zygo Corporation |
Interferometer and method for measuring the refractive index and optical path length effects of air
|
US20020090639A1
(en)
*
|
1998-02-26 |
2002-07-11 |
Mcginnis Ralph Evan |
Two dimensional linkage study methods and related inventions
|
EP1068356B8
(de)
*
|
1998-04-03 |
2007-01-03 |
Adnexus Therapeutics, Inc. |
Adressierbare protein arrays
|
US6733967B1
(en)
|
1998-04-21 |
2004-05-11 |
Interleukin Genetics, Inc. |
Fetal testing for prediction of low birth weight
|
US7094943B2
(en)
|
1998-04-27 |
2006-08-22 |
Hubert Köster |
Solution phase biopolymer synthesis
|
US6723564B2
(en)
|
1998-05-07 |
2004-04-20 |
Sequenom, Inc. |
IR MALDI mass spectrometry of nucleic acids using liquid matrices
|
DE19822287C2
(de)
|
1998-05-18 |
2003-04-24 |
Switch Biotech Ag |
Klonierungsvektor, seine Herstellung und Verwendung zur Analyse von mRNA Expressionsmuster
|
WO1999061910A1
(en)
*
|
1998-05-26 |
1999-12-02 |
Board Of Trustees Of The University Of Illinois |
Screening of compounds using ultrafiltration and mass spectometry
|
US6104028A
(en)
*
|
1998-05-29 |
2000-08-15 |
Genetrace Systems Inc. |
Volatile matrices for matrix-assisted laser desorption/ionization mass spectrometry
|
DE19824280B4
(de)
*
|
1998-05-29 |
2004-08-19 |
Bruker Daltonik Gmbh |
Mutationsanalyse mittels Massenspektrometrie
|
US6872521B1
(en)
|
1998-06-16 |
2005-03-29 |
Beckman Coulter, Inc. |
Polymerase signaling assay
|
DE69936168T2
(de)
|
1998-06-18 |
2007-09-27 |
Micromass UK Ltd., Simonsway |
Mehrfachprobeninlassmassenspektrometer
|
US6218118B1
(en)
|
1998-07-09 |
2001-04-17 |
Agilent Technologies, Inc. |
Method and mixture reagents for analyzing the nucleotide sequence of nucleic acids by mass spectrometry
|
US6270976B1
(en)
*
|
1998-09-15 |
2001-08-07 |
Brax Group Limited |
Characterizing nucleic acid by mass spectrometry
|
AU9505798A
(en)
*
|
1998-09-24 |
2000-04-10 |
Biotraces, Inc. |
Sequencing duplex dna by mass spectroscopy
|
US6610492B1
(en)
|
1998-10-01 |
2003-08-26 |
Variagenics, Inc. |
Base-modified nucleotides and cleavage of polynucleotides incorporating them
|
US6855500B2
(en)
|
1998-10-01 |
2005-02-15 |
Sequenom, Inc. |
Fluorescence-based genotyping
|
US6440705B1
(en)
|
1998-10-01 |
2002-08-27 |
Vincent P. Stanton, Jr. |
Method for analyzing polynucleotides
|
US6500650B1
(en)
|
1998-10-01 |
2002-12-31 |
Variagenics, Inc. |
Method for identifying polymorphisms
|
US6777188B2
(en)
|
1998-10-01 |
2004-08-17 |
Variagenics, Inc. |
Genotyping by mass spectrometric analysis of allelic fragments
|
US6566059B1
(en)
|
1998-10-01 |
2003-05-20 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6458945B1
(en)
|
1998-10-01 |
2002-10-01 |
Variagenics, Inc. |
Method for analyzing polynucleotides
|
US6994998B1
(en)
|
1998-10-01 |
2006-02-07 |
Sequenom, Inc. |
Base-modified nucleotides and their use for polymorphism detection
|
DE19852167C2
(de)
*
|
1998-11-12 |
2000-12-14 |
Bruker Saxonia Analytik Gmbh |
Einfache SNP-Analyse mittels Massenspektrometrie
|
DE19905082C1
(de)
*
|
1999-01-29 |
2000-05-18 |
Epigenomics Gmbh |
Verfahren zur Identifikation von Cytosin-Methylierungsmustern in genomischen DNA-Proben
|
JP2003518914A
(ja)
|
1999-02-10 |
2003-06-17 |
キュリス インコーポレイテッド |
グルコース代謝障害を治療する方法および試薬
|
US7745216B2
(en)
|
1999-02-10 |
2010-06-29 |
Curis, Inc. |
Methods and reagents for treating glucose metabolic disorders
|
CA2361384A1
(en)
|
1999-02-11 |
2000-08-17 |
Sun Ai Raillard |
High throughput mass spectrometry
|
EP2301947A3
(de)
|
1999-02-26 |
2011-11-23 |
Millennium Pharmaceuticals, Inc. |
Sekretierte Proteine und Verwendungen dafür
|
US6225061B1
(en)
|
1999-03-10 |
2001-05-01 |
Sequenom, Inc. |
Systems and methods for performing reactions in an unsealed environment
|
US6858439B1
(en)
|
1999-03-15 |
2005-02-22 |
Aviva Biosciences |
Compositions and methods for separation of moieties on chips
|
TW496775B
(en)
|
1999-03-15 |
2002-08-01 |
Aviva Bioscience Corp |
Individually addressable micro-electromagnetic unit array chips
|
CN1185492C
(zh)
|
1999-03-15 |
2005-01-19 |
清华大学 |
可单点选通式微电磁单元阵列芯片、电磁生物芯片及应用
|
US6436640B1
(en)
*
|
1999-03-18 |
2002-08-20 |
Exiqon A/S |
Use of LNA in mass spectrometry
|
US20020009394A1
(en)
|
1999-04-02 |
2002-01-24 |
Hubert Koster |
Automated process line
|
US6994969B1
(en)
*
|
1999-04-30 |
2006-02-07 |
Methexis Genomics, N.V. |
Diagnostic sequencing by a combination of specific cleavage and mass spectrometry
|
US7056661B2
(en)
|
1999-05-19 |
2006-06-06 |
Cornell Research Foundation, Inc. |
Method for sequencing nucleic acid molecules
|
US7396905B1
(en)
|
1999-05-21 |
2008-07-08 |
Mckeon Frank |
Calcipressins: endogenous inhibitors of calcineurin, uses and reagents related thereto
|
WO2000077812A2
(en)
*
|
1999-06-10 |
2000-12-21 |
Northeastern University |
Light-induced electron capture at a surface
|
CA2378221A1
(en)
|
1999-06-30 |
2001-01-04 |
Interleukin Genetics, Inc. |
Diagnostics and therapeutics for diseases associated with an il-1 inflammatory haplotype
|
US7291714B1
(en)
|
1999-06-30 |
2007-11-06 |
Millennium Pharmaceuticals, Inc. |
Glycoprotein VI and uses thereof
|
US6573049B1
(en)
|
1999-07-26 |
2003-06-03 |
Nuvelo, Inc. |
Genotyping of the paraoxonase 1 gene for prognosing, diagnosing, and treating a disease
|
US6808710B1
(en)
|
1999-08-23 |
2004-10-26 |
Genetics Institute, Inc. |
Downmodulating an immune response with multivalent antibodies to PD-1
|
US6982146B1
(en)
*
|
1999-08-30 |
2006-01-03 |
The United States Of America As Represented By The Department Of Health And Human Services |
High speed parallel molecular nucleic acid sequencing
|
EP1235932A2
(de)
|
1999-10-08 |
2002-09-04 |
Protogene Laboratories, Inc. |
Verfahren und vorrichtung zur durchführung von hohen zahlen von reaktionen unter benutzung von arrays
|
US20030207297A1
(en)
*
|
1999-10-13 |
2003-11-06 |
Hubert Koster |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7332275B2
(en)
*
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
US7917301B1
(en)
|
2000-09-19 |
2011-03-29 |
Sequenom, Inc. |
Method and device for identifying a biological sample
|
EP2088209B1
(de)
|
1999-10-13 |
2017-05-31 |
Sequenom, Inc. |
Verfahren zur Erzeugung von Datenbanken zur Identifizierung von polymorphen genetischen Markern
|
WO2001037878A2
(en)
*
|
1999-11-29 |
2001-05-31 |
Orchid Biosciences, Inc. |
Methods of identifying optimal drug combinations and compositions thereof
|
AU745917C
(en)
*
|
1999-12-08 |
2007-03-29 |
Agouron Pharmaceuticals, Inc. |
High-throughput screening of compounds using electrospray ionization mass spectrometry
|
US20030022318A1
(en)
*
|
2000-01-25 |
2003-01-30 |
Epiclone, Inc. |
Method for thermocycling amplification of nucleic acid sequences and the generation of related peptides thereof
|
EP1257664A4
(de)
*
|
2000-01-28 |
2006-04-05 |
Althea Technologies Inc |
Verfahren zur analyse der genexpression
|
KR100748297B1
(ko)
|
2000-02-29 |
2007-08-09 |
알콘, 인코퍼레이티드 |
녹내장의 진단법 및 치료법
|
US6686461B1
(en)
|
2000-03-22 |
2004-02-03 |
Solulink Bioscience, Inc. |
Triphosphate oligonucleotide modification reagents and uses thereof
|
US7102024B1
(en)
|
2000-08-01 |
2006-09-05 |
Schwartz David A |
Functional biopolymer modification reagents and uses thereof
|
EP1274996A4
(de)
*
|
2000-04-13 |
2006-02-01 |
Thermo Finnigan Llc |
Proteomische analyse durch parallele massenspektrometrie
|
ES2316446T3
(es)
|
2000-04-29 |
2009-04-16 |
University Of Iowa Research Foundation |
Diagnostico y terapeutica para trastornos relacionados con la degeneracion macular.
|
US6475736B1
(en)
*
|
2000-05-23 |
2002-11-05 |
Variagenics, Inc. |
Methods for genetic analysis of DNA using biased amplification of polymorphic sites
|
ATE423221T1
(de)
*
|
2000-06-13 |
2009-03-15 |
Univ Boston |
Verwendung von mass-matched nukleotide in der analyse von oligonukleotidmischungen sowie in der hoch-multiplexen nukleinsäuresequenzierung
|
EP1975251A3
(de)
*
|
2000-07-07 |
2009-03-25 |
Visigen Biotechnologies, Inc. |
Sequenzbestimmung in Echtzeit
|
US6958214B2
(en)
|
2000-07-10 |
2005-10-25 |
Sequenom, Inc. |
Polymorphic kinase anchor proteins and nucleic acids encoding the same
|
JP2004504038A
(ja)
*
|
2000-07-13 |
2004-02-12 |
ザ ジョンズ ホプキンス ユニバーシティー スクール オブ メディシン |
多発性嚢胞腎疾患の検出と治療
|
US6803211B2
(en)
|
2000-08-25 |
2004-10-12 |
Pfizer Inc. |
Methods and compositions for diagnosing and treating disorders involving angiogenesis
|
GB0021286D0
(en)
*
|
2000-08-30 |
2000-10-18 |
Gemini Genomics Ab |
Identification of drug metabolic capacity
|
US6548251B1
(en)
|
2000-09-05 |
2003-04-15 |
Fidelity Systems, Inc. |
Inhibition of molecular and biological processes using modified oligonucleotides
|
US6747142B1
(en)
|
2000-09-05 |
2004-06-08 |
Fidelity Systems, Inc. |
Multiple methoxyoxalamido and succinimido precursors for nucleophilic addition
|
US6963807B2
(en)
|
2000-09-08 |
2005-11-08 |
Oxford Glycosciences (Uk) Ltd. |
Automated identification of peptides
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
IL155281A0
(en)
*
|
2000-10-19 |
2003-11-23 |
Target Discovery Inc |
Methods for determining protein and peptide terminal sequences
|
US6479242B1
(en)
|
2000-10-26 |
2002-11-12 |
Cleveland State University |
Method for genotyping of single nucleotide polymorphism
|
US20020142483A1
(en)
|
2000-10-30 |
2002-10-03 |
Sequenom, Inc. |
Method and apparatus for delivery of submicroliter volumes onto a substrate
|
NZ526708A
(en)
|
2000-11-28 |
2005-07-29 |
Wyeth Corp |
Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
|
BR0115728A
(pt)
|
2000-11-28 |
2003-09-23 |
Wyeth Corp |
Análise da expressão de ácidos nucléicos kiaa e polipeptìdeos úteis no diagnóstico e tratamento de cáncer de próstata
|
EP1354064A2
(de)
|
2000-12-01 |
2003-10-22 |
Visigen Biotechnologies, Inc. |
Enzymatische nukleinsäuresynthese: zusammensetzungen und verfahren, um die zuverlässigkeit des monomereinbaus zu erhöhen
|
EP2341060B1
(de)
|
2000-12-12 |
2019-02-20 |
MedImmune, LLC |
Moleküle mit längeren Halbwertszeiten, Zusammensetzungen und deren Verwendung
|
BR0116206A
(pt)
|
2000-12-14 |
2003-12-23 |
Amylin Pharmaceuticals Inc |
Peptìdeo yy e agonistas de peptìdeo yy para tratamento de distúrbios metabólicos
|
WO2002050276A2
(en)
*
|
2000-12-18 |
2002-06-27 |
Curagen Corporation |
Proteins and nucleic acids encoding same
|
WO2002052045A1
(en)
*
|
2000-12-26 |
2002-07-04 |
Aviva Biosciences |
Active and biocompatible platforms prepared by polymerization of surface coating films
|
FI115139B
(fi)
*
|
2001-01-10 |
2005-03-15 |
Valtion Teknillinen |
Menetelmä ja testipakkaus solu- tai kudosnäytteissä olevien polynukleotidien määrässä tapahtuvien vaihteluiden kvantitatiiviseen ja/tai vertailevaan arvioimiseen
|
DE10108453B4
(de)
*
|
2001-02-22 |
2005-10-20 |
Bruker Daltonik Gmbh |
Massenspektrometrische Mutationsanalyse mit photolytisch spaltbaren Primern
|
EP1234887B1
(de)
*
|
2001-02-27 |
2005-09-28 |
Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts |
Verfahren zur Bindung von Nukleinsäuren an einen Träger
|
US20030027135A1
(en)
|
2001-03-02 |
2003-02-06 |
Ecker David J. |
Method for rapid detection and identification of bioagents
|
US20040121309A1
(en)
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in blood, bodily fluids, and bodily tissues
|
US7226739B2
(en)
|
2001-03-02 |
2007-06-05 |
Isis Pharmaceuticals, Inc |
Methods for rapid detection and identification of bioagents in epidemiological and forensic investigations
|
US20040121310A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in forensic studies
|
US20040121314A1
(en)
*
|
2002-12-06 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of bioagents in containers
|
US7718354B2
(en)
*
|
2001-03-02 |
2010-05-18 |
Ibis Biosciences, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US7666588B2
(en)
|
2001-03-02 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for rapid forensic analysis of mitochondrial DNA and characterization of mitochondrial DNA heteroplasmy
|
WO2002074929A2
(en)
*
|
2001-03-19 |
2002-09-26 |
President And Fellows Of Harvard College |
Evolving new molecular function
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
WO2002079499A1
(en)
|
2001-04-02 |
2002-10-10 |
Wyeth |
Pd-1, a receptor for b7-4, and uses therefor
|
MXPA03009415A
(es)
|
2001-04-16 |
2004-01-29 |
Wyeth Corp |
ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
|
US20020155587A1
(en)
|
2001-04-20 |
2002-10-24 |
Sequenom, Inc. |
System and method for testing a biological sample
|
GB0111324D0
(en)
|
2001-05-09 |
2001-07-04 |
Unilever Plc |
Ambient stable beverage
|
WO2002102820A1
(en)
*
|
2001-06-20 |
2002-12-27 |
Nuevolution A/S |
Nucleoside derivatives for library preparation
|
US7217510B2
(en)
|
2001-06-26 |
2007-05-15 |
Isis Pharmaceuticals, Inc. |
Methods for providing bacterial bioagent characterizing information
|
US8073627B2
(en)
|
2001-06-26 |
2011-12-06 |
Ibis Biosciences, Inc. |
System for indentification of pathogens
|
US7668697B2
(en)
*
|
2006-02-06 |
2010-02-23 |
Andrei Volkov |
Method for analyzing dynamic detectable events at the single molecule level
|
EP1481076A4
(de)
|
2001-07-12 |
2005-05-11 |
Illumina Inc |
Multiplex-nukleinsäurereaktionen
|
DE60230927D1
(de)
|
2001-07-16 |
2009-03-05 |
Caprotec Bioanalytics Gmbh |
Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen
|
WO2003054143A2
(en)
*
|
2001-10-25 |
2003-07-03 |
Neurogenetics, Inc. |
Genes and polymorphisms on chromosome 10 associated with alzheimer's disease and other neurodegenerative diseases
|
US20030170678A1
(en)
*
|
2001-10-25 |
2003-09-11 |
Neurogenetics, Inc. |
Genetic markers for Alzheimer's disease and methods using the same
|
US20030224380A1
(en)
*
|
2001-10-25 |
2003-12-04 |
The General Hospital Corporation |
Genes and polymorphisms on chromosome 10 associated with Alzheimer's disease and other neurodegenerative diseases
|
AU2002348099A1
(en)
|
2001-10-26 |
2003-05-06 |
Sequenom Inc. |
Resin dispensing device
|
US20030162202A1
(en)
*
|
2001-11-09 |
2003-08-28 |
Becker Kenneth David |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
US20040067512A1
(en)
*
|
2001-11-09 |
2004-04-08 |
Neurogenetics, Inc. |
Single nucleotide polymorphisms and mutations on Alpha-2-Macroglobulin
|
AU2002367355A1
(en)
*
|
2001-12-31 |
2003-07-24 |
3M Innovative Properties Company |
Methods of processing sample processing devices
|
AU2003201159A1
(en)
|
2002-01-08 |
2003-07-24 |
Bayer Healthcare Ag |
Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy
|
ES2319634T3
(es)
*
|
2002-03-11 |
2009-05-11 |
Caprotec Bioanalytics Gmbh |
Compuestos y metodos para analizar el proteoma.
|
US20050164193A1
(en)
*
|
2002-03-25 |
2005-07-28 |
Epigenomics Ag |
Method for the analysis of methylation patterns within nucleic acids by means of mass spectrometry
|
US6723546B2
(en)
*
|
2002-03-26 |
2004-04-20 |
New England Biolabs, Inc. |
Method for cloning and expression of BsaI restriction endonuclease and BsaI methylase in E. coli
|
WO2003083130A2
(en)
|
2002-03-28 |
2003-10-09 |
The Johns Hopkins University |
Detection of malaria parasites by mass spectrometry
|
WO2003100035A2
(en)
*
|
2002-04-01 |
2003-12-04 |
Isis Pharmaceuticals, Inc. |
Method for rapid detection and identification of viral bioagents
|
WO2003093296A2
(en)
|
2002-05-03 |
2003-11-13 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20030220844A1
(en)
*
|
2002-05-24 |
2003-11-27 |
Marnellos Georgios E. |
Method and system for purchasing genetic data
|
US6906163B2
(en)
*
|
2002-05-30 |
2005-06-14 |
Bayer Materialscience Llc |
Prepolymer catalysts suitable for preparing spandex fibers
|
WO2003101177A2
(en)
*
|
2002-06-04 |
2003-12-11 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
|
AU2003248794B2
(en)
*
|
2002-06-27 |
2007-10-04 |
Harkness Pharmaceuticals, Inc. |
Therapeutic methods for reducing fat deposition and treating associated conditions
|
WO2004002295A2
(en)
*
|
2002-06-27 |
2004-01-08 |
Sequenom, Inc. |
Diagnosing predisposition to fat deposition and associated condition
|
US20040137491A1
(en)
*
|
2002-06-28 |
2004-07-15 |
Tadashi Okamoto |
Method of analyzing probe carrier using time-of-flight secondary ion mass spectrometry
|
EP2385139A1
(de)
|
2002-07-31 |
2011-11-09 |
University of Southern California |
Polymorphismen zur Vorhersage des Krankheits- und Behandlungsausgangs
|
JP4657919B2
(ja)
*
|
2002-08-19 |
2011-03-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
進化する新しい分子機能
|
WO2005027710A2
(en)
*
|
2002-09-11 |
2005-03-31 |
Sequenom, Inc. |
Methods for identifying subjects at risk of melanoma and treatments thereof
|
WO2004044163A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Sequenom, Inc. |
Methods for identifying risk of melanoma and treatments thereof
|
EP2112229A3
(de)
|
2002-11-25 |
2009-12-02 |
Sequenom, Inc. |
Verfahren zum Identifizieren des Brustkrebsrisikos und zugehörige Behandlungen
|
WO2004048548A2
(en)
*
|
2002-11-25 |
2004-06-10 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
WO2004047623A2
(en)
*
|
2002-11-25 |
2004-06-10 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
AU2003293130A1
(en)
*
|
2002-11-25 |
2004-06-18 |
Sequenom, Inc. |
Methods for identifying risk of breast cancer and treatments thereof
|
CA2507189C
(en)
|
2002-11-27 |
2018-06-12 |
Sequenom, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
CA2508726A1
(en)
|
2002-12-06 |
2004-07-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of pathogens in humans and animals
|
US20040115655A1
(en)
*
|
2002-12-16 |
2004-06-17 |
Ilsley Diane D. |
Method for analyzing the nucleotide sequence of nucleic acids
|
US20040121312A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Methods for rapid detection and identification of the absence of bioagents
|
US20040122857A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in forensic studies thereby
|
US20040121315A1
(en)
*
|
2002-12-18 |
2004-06-24 |
Ecker David J. |
Secondary structure defining database and methods for determining identity and geographic origin of an unknown bioagent in containers thereby
|
CA2886504C
(en)
|
2002-12-20 |
2019-01-08 |
Celera Corporation |
Wdr12 polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
EP2368578A1
(de)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identifizierung und Herstellung von Antikörpern mit abweichenden FC-Regionen und Anwendungsverfahren dafür
|
EP2272533A1
(de)
|
2003-01-13 |
2011-01-12 |
MacroGenics, Inc. |
Lösliche FcyR-Fusionsproteine und Verfahren zu deren Verwendung
|
JP4741458B2
(ja)
*
|
2003-01-16 |
2011-08-03 |
カプロテック・バイオアナリティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング |
捕獲化合物、その収集物ならびにプロテオームおよび複合組成物を分析するための方法
|
US20090186343A1
(en)
*
|
2003-01-28 |
2009-07-23 |
Visigen Biotechnologies, Inc. |
Methods for preparing modified biomolecules, modified biomolecules and methods for using same
|
US20040157220A1
(en)
|
2003-02-10 |
2004-08-12 |
Purnima Kurnool |
Methods and apparatus for sample tracking
|
US20070141570A1
(en)
*
|
2003-03-07 |
2007-06-21 |
Sequenom, Inc. |
Association of polymorphic kinase anchor proteins with cardiac phenotypes and related methods
|
US8507285B2
(en)
*
|
2003-03-13 |
2013-08-13 |
Agilent Technologies, Inc. |
Methods and devices for identifying biopolymers using mass spectroscopy
|
US8017323B2
(en)
*
|
2003-03-26 |
2011-09-13 |
President And Fellows Of Harvard College |
Free reactant use in nucleic acid-templated synthesis
|
US8046171B2
(en)
|
2003-04-18 |
2011-10-25 |
Ibis Biosciences, Inc. |
Methods and apparatus for genetic evaluation
|
US20050009053A1
(en)
*
|
2003-04-25 |
2005-01-13 |
Sebastian Boecker |
Fragmentation-based methods and systems for de novo sequencing
|
US8057993B2
(en)
|
2003-04-26 |
2011-11-15 |
Ibis Biosciences, Inc. |
Methods for identification of coronaviruses
|
US7964343B2
(en)
|
2003-05-13 |
2011-06-21 |
Ibis Biosciences, Inc. |
Method for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US8158354B2
(en)
|
2003-05-13 |
2012-04-17 |
Ibis Biosciences, Inc. |
Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
|
US20040248104A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Zohar Yakhini |
Methods and reagents for profiling quantities of nucleic acids
|
US7947817B2
(en)
*
|
2003-06-30 |
2011-05-24 |
Roche Molecular Systems, Inc. |
Synthesis and compositions of 2'-terminator nucleotides
|
US7572581B2
(en)
|
2003-06-30 |
2009-08-11 |
Roche Molecular Systems, Inc. |
2′-terminator nucleotide-related methods and systems
|
US20050233341A1
(en)
*
|
2003-07-23 |
2005-10-20 |
Roth Richard R |
Methods for identifying risk of melanoma and treatments thereof
|
US20050272043A1
(en)
*
|
2003-07-24 |
2005-12-08 |
Roth Richard B |
Methods for identifying risk of breast cancer and treatments thereof
|
EP1660680B1
(de)
|
2003-07-31 |
2009-03-11 |
Sequenom, Inc. |
Verfahren für multiplex-polymerasekettenreaktionen auf hohem niveau und homogenen massenverlängerungsreaktionen zur genotypisierung von polymorphismen
|
WO2005013809A2
(en)
|
2003-08-08 |
2005-02-17 |
Interleukin Genetics, Inc. |
Diagnostic and therapeutics for osteoporosis
|
US20050123952A1
(en)
*
|
2003-09-04 |
2005-06-09 |
Griffey Richard H. |
Methods of rapid detection and identification of bioagents using microRNA
|
US9394565B2
(en)
|
2003-09-05 |
2016-07-19 |
Agena Bioscience, Inc. |
Allele-specific sequence variation analysis
|
US7956175B2
(en)
|
2003-09-11 |
2011-06-07 |
Ibis Biosciences, Inc. |
Compositions for use in identification of bacteria
|
US8546082B2
(en)
|
2003-09-11 |
2013-10-01 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US8097416B2
(en)
|
2003-09-11 |
2012-01-17 |
Ibis Biosciences, Inc. |
Methods for identification of sepsis-causing bacteria
|
US20100129811A1
(en)
*
|
2003-09-11 |
2010-05-27 |
Ibis Biosciences, Inc. |
Compositions for use in identification of pseudomonas aeruginosa
|
US20100035239A1
(en)
*
|
2003-09-11 |
2010-02-11 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of bacteria
|
ES2453895T3
(es)
*
|
2003-09-23 |
2014-04-08 |
University Of North Carolina At Chapel Hill |
Células que expresan vitamina K epóxido reductasa y uso de las mismas
|
US20050142584A1
(en)
*
|
2003-10-01 |
2005-06-30 |
Willson Richard C. |
Microbial identification based on the overall composition of characteristic oligonucleotides
|
AU2004286265A1
(en)
*
|
2003-10-29 |
2005-05-12 |
Ribomed Biotechnologies, Inc. |
Compositions, methods and detection technologies for reiterative oligonucleotide synthesis
|
CA3050151C
(en)
|
2003-11-26 |
2023-03-07 |
Celera Corporation |
Single nucleotide polymorphisms associated with cardiovascular disorders and statin response, methods of detection and uses thereof
|
US7662389B2
(en)
|
2003-12-17 |
2010-02-16 |
Alcon, Inc. |
Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
|
US20100113481A1
(en)
|
2003-12-17 |
2010-05-06 |
Alcon Research, Ltd. |
Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
|
TWI398261B
(zh)
|
2003-12-17 |
2013-06-11 |
Alcon Inc |
血清類澱粉a基因於診斷及治療青光眼及鑑定抗青光眼劑上之用途
|
US20090197246A1
(en)
*
|
2004-01-10 |
2009-08-06 |
Udo Stropp |
Haplotypes and polymorphisms linked to human thiopurine s-methyltransferase deficiencies
|
WO2005073409A2
(en)
*
|
2004-01-26 |
2005-08-11 |
Applera Corporation |
Methods, compositions, and kits for amplifying and sequencing polynucleotides
|
JP5638177B2
(ja)
|
2004-02-11 |
2014-12-10 |
アミリン・ファーマシューティカルズ, リミテッド・ライアビリティ・カンパニーAmylin Pharmaceuticals, Llc |
膵臓ポリペプチドファミリーモチーフおよびそのモチーフを含むポリペプチド
|
US7666592B2
(en)
|
2004-02-18 |
2010-02-23 |
Ibis Biosciences, Inc. |
Methods for concurrent identification and quantification of an unknown bioagent
|
US8119336B2
(en)
|
2004-03-03 |
2012-02-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of alphaviruses
|
WO2005098050A2
(en)
|
2004-03-26 |
2005-10-20 |
Sequenom, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
US7608394B2
(en)
|
2004-03-26 |
2009-10-27 |
Sequenom, Inc. |
Methods and compositions for phenotype identification based on nucleic acid methylation
|
EP1745154B1
(de)
|
2004-05-07 |
2012-08-01 |
Celera Corporation |
Genetische polymorphismen assoziiert mit leberfibrose, verfahren zur detektion und verwendung davon
|
WO2005113804A1
(en)
*
|
2004-05-20 |
2005-12-01 |
Trillion Genomics Limited |
Use of mass labelled probes to detect target nucleic acids using mass spectrometry
|
EP1756136B1
(de)
*
|
2004-05-21 |
2014-10-29 |
Mo Bio Laboratories, Inc. |
Kits und verfahren zur entfernung von verunreinigungen aus nukleinsäuren bei biologischen proben und umweltproben
|
WO2005117270A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Isis Pharmaceuticals, Inc. |
Mass spectrometry with selective ion filtration by digital thresholding
|
US20050266411A1
(en)
*
|
2004-05-25 |
2005-12-01 |
Hofstadler Steven A |
Methods for rapid forensic analysis of mitochondrial DNA
|
EP1766051A4
(de)
*
|
2004-05-27 |
2007-10-10 |
Sequenom Inc |
Verfahren zur identifizierung des brustkrebsrisikos und behandlungen davon
|
US7745125B2
(en)
*
|
2004-06-28 |
2010-06-29 |
Roche Molecular Systems, Inc. |
2′-terminator related pyrophosphorolysis activated polymerization
|
US7928207B2
(en)
*
|
2004-06-28 |
2011-04-19 |
Roche Molecular Systems, Inc |
Synthesis and compositions of nucleic acids comprising 2′-terminator nucleotides
|
US7811753B2
(en)
|
2004-07-14 |
2010-10-12 |
Ibis Biosciences, Inc. |
Methods for repairing degraded DNA
|
US20080199480A1
(en)
*
|
2004-07-22 |
2008-08-21 |
Sequenom, Inc. |
Methods for Identifying Risk of Type II Diabetes and Treatments Thereof
|
WO2006135400A2
(en)
|
2004-08-24 |
2006-12-21 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification of recombinant organisms
|
US20060073501A1
(en)
*
|
2004-09-10 |
2006-04-06 |
Van Den Boom Dirk J |
Methods for long-range sequence analysis of nucleic acids
|
US7170050B2
(en)
*
|
2004-09-17 |
2007-01-30 |
Pacific Biosciences Of California, Inc. |
Apparatus and methods for optical analysis of molecules
|
CA2579150C
(en)
*
|
2004-09-17 |
2014-11-25 |
Pacific Biosciences Of California, Inc. |
Apparatus and method for analysis of molecules
|
US7445896B2
(en)
*
|
2004-10-18 |
2008-11-04 |
University Of Washington |
Methods and compositions for detecting VKORC1 single nucleotide polymorphisms
|
US20090118132A1
(en)
*
|
2004-11-04 |
2009-05-07 |
Roche Molecular Systems, Inc. |
Classification of Acute Myeloid Leukemia
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
US7700287B2
(en)
*
|
2005-01-28 |
2010-04-20 |
Life Technologies Corporation |
Compositions and methods for terminating a sequencing reaction at a specific location in a target DNA template
|
WO2006094238A2
(en)
|
2005-03-03 |
2006-09-08 |
Isis Pharmaceuticals, Inc. |
Compositions for use in identification of adventitious viruses
|
US8084207B2
(en)
|
2005-03-03 |
2011-12-27 |
Ibis Bioscience, Inc. |
Compositions for use in identification of papillomavirus
|
WO2006099365A2
(en)
|
2005-03-11 |
2006-09-21 |
Applera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
CA2601574C
(en)
*
|
2005-03-15 |
2014-12-02 |
University Of North Carolina At Chapel Hill |
Methods and compositions for producing active vitamin k-dependent proteins
|
ES2261072B1
(es)
*
|
2005-04-06 |
2007-12-16 |
Consejo Superior Investig. Cientificas |
Fosforotioatos derivados de analogos a nucleosido para terapia antirretroviral.
|
EP1874811B1
(de)
|
2005-04-15 |
2012-06-13 |
President and Fellows of Harvard College |
Verfahren zur Modulation der Knochenbildung und -mineralisation durch Modulation der KRC-Aktivität
|
CA2616281C
(en)
|
2005-07-21 |
2014-04-22 |
Isis Pharmaceuticals, Inc. |
Methods for rapid identification and quantitation of mitochondrial dna variants
|
SI2573114T1
(sl)
|
2005-08-10 |
2016-08-31 |
Macrogenics, Inc. |
Identifikacija in inženiring protiteles z variantnimi fc regijami in postopki za njih uporabo
|
ATE501278T1
(de)
|
2005-09-22 |
2011-03-15 |
Inst Nat Sante Rech Med |
Verfahren zur verwendung von il-21
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US8105775B2
(en)
|
2005-10-25 |
2012-01-31 |
Interleukin Genetics, Inc. |
IL-1 gene cluster and associated inflammatory polymorphisms and haplotypes
|
EP1948235B1
(de)
|
2005-11-01 |
2013-08-28 |
AbbVie Biotechnology Ltd |
Methoden zur bestimmung der wirksamkeit von adalimumab bei patienten mit morbus bechterew mit ctx-ii und mmp3 als biomarker
|
WO2007053732A2
(en)
|
2005-11-01 |
2007-05-10 |
Mayo Foundation For Medical Education And Research |
Promoter polymorphisms of the blys gene and use in diagnostic methods
|
WO2007070572A2
(en)
*
|
2005-12-12 |
2007-06-21 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Probe for nucleic acid sequencing and methods of use
|
US8703734B2
(en)
|
2005-12-12 |
2014-04-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoprobes for detection or modification of molecules
|
US8457900B2
(en)
*
|
2006-03-23 |
2013-06-04 |
The Regents Of The University Of California |
Method for identification and sequencing of proteins
|
EP2010679A2
(de)
|
2006-04-06 |
2009-01-07 |
Ibis Biosciences, Inc. |
Zusammensetzungen für die identifizierung von pilzen
|
CA2650730A1
(en)
|
2006-04-27 |
2007-11-08 |
Pikamab, Inc. |
Methods and compositions for antibody therapy
|
EP2029776A4
(de)
*
|
2006-05-30 |
2010-01-20 |
Synergenz Bioscience Ltd |
Verfahren und zusammensetzungen zur beurteilung von lungenfunktion und lungenleiden
|
EP2602321B1
(de)
|
2006-05-31 |
2017-08-23 |
Sequenom, Inc. |
Verfahren und Zusammensetzungen zur Nukleinsäureextraktion und -verstärkung aus einer Probe
|
US8153369B2
(en)
|
2006-06-05 |
2012-04-10 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
US7772390B1
(en)
|
2006-07-18 |
2010-08-10 |
The Regents Of The University Of California |
Lipid mediated nucleic acid synthesis
|
US20080091005A1
(en)
*
|
2006-07-20 |
2008-04-17 |
Visigen Biotechnologies, Inc. |
Modified nucleotides, methods for making and using same
|
US20080241938A1
(en)
*
|
2006-07-20 |
2008-10-02 |
Visigen Biotechnologies, Inc. |
Automated synthesis or sequencing apparatus and method for making and using same
|
US20080241951A1
(en)
*
|
2006-07-20 |
2008-10-02 |
Visigen Biotechnologies, Inc. |
Method and apparatus for moving stage detection of single molecular events
|
US9582639B2
(en)
|
2006-08-11 |
2017-02-28 |
University Of Tennessee Research Foundation |
Method and apparatus for mobile disaster victim identification
|
AU2007353877B2
(en)
|
2006-09-14 |
2012-07-19 |
Ibis Biosciences, Inc. |
Targeted whole genome amplification method for identification of pathogens
|
JP2010506842A
(ja)
|
2006-10-16 |
2010-03-04 |
メディミューン,エルエルシー |
半減期が短縮された分子、その組成物および使用
|
CA2915679C
(en)
|
2006-10-20 |
2017-12-12 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
US7902345B2
(en)
|
2006-12-05 |
2011-03-08 |
Sequenom, Inc. |
Detection and quantification of biomolecules using mass spectrometry
|
WO2008076842A2
(en)
*
|
2006-12-14 |
2008-06-26 |
Applied Biosystems Inc. |
Sequencing methods
|
AU2008205457A1
(en)
*
|
2007-01-18 |
2008-07-24 |
University Of Southern California |
Gene polymorphisms predictive for dual TKI therapy
|
US8076104B2
(en)
*
|
2007-01-25 |
2011-12-13 |
Rogan Peter K |
Rapid and comprehensive identification of prokaryotic organisms
|
WO2008098142A2
(en)
|
2007-02-08 |
2008-08-14 |
Sequenom, Inc. |
Nucleic acid-based tests for rhd typing, gender determination and nucleic acid quantification
|
WO2008104002A2
(en)
|
2007-02-23 |
2008-08-28 |
Ibis Biosciences, Inc. |
Methods for rapid forensic dna analysis
|
US20110189663A1
(en)
|
2007-03-05 |
2011-08-04 |
Cancer Care Ontario |
Assessment of risk for colorectal cancer
|
AU2008230813B2
(en)
|
2007-03-26 |
2014-01-30 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
US20080241831A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Jian-Bing Fan |
Methods for detecting small RNA species
|
US7811766B2
(en)
*
|
2007-03-28 |
2010-10-12 |
Thinkvillage, Llc |
Genetic identification and validation of Echinacea species
|
US20090006002A1
(en)
*
|
2007-04-13 |
2009-01-01 |
Sequenom, Inc. |
Comparative sequence analysis processes and systems
|
US8527207B2
(en)
*
|
2007-05-15 |
2013-09-03 |
Peter K. Rogan |
Accurate identification of organisms based on individual information content
|
WO2009023358A2
(en)
*
|
2007-05-25 |
2009-02-19 |
Ibis Biosciences, Inc. |
Compositions for use in identification of strains of hepatitis c virus
|
EP2527472B1
(de)
|
2007-05-31 |
2016-09-28 |
Yale University |
Mit Krebs assoziierte genetische Läsion
|
US9598724B2
(en)
|
2007-06-01 |
2017-03-21 |
Ibis Biosciences, Inc. |
Methods and compositions for multiple displacement amplification of nucleic acids
|
JP5494480B2
(ja)
*
|
2007-06-11 |
2014-05-14 |
和光純薬工業株式会社 |
集積リアルタイムce検出を用いるマイクロチップ大容量pcr
|
WO2009038840A2
(en)
*
|
2007-06-14 |
2009-03-26 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious contaminant viruses
|
US9404150B2
(en)
|
2007-08-29 |
2016-08-02 |
Sequenom, Inc. |
Methods and compositions for universal size-specific PCR
|
AU2008298904B2
(en)
|
2007-09-14 |
2014-10-16 |
Amgen Inc. |
Homogeneous antibody populations
|
WO2009039122A2
(en)
|
2007-09-17 |
2009-03-26 |
Sequenom, Inc. |
Integrated robotic sample transfer device
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
JP5580205B2
(ja)
|
2007-11-19 |
2014-08-27 |
セレラ コーポレーション |
肺癌マーカーとその使用
|
WO2009073511A2
(en)
|
2007-11-30 |
2009-06-11 |
Mayo Foundation For Medical Education And Research |
Polymorphisms of the blys gene and use in diagnostic methods
|
CN101896624A
(zh)
*
|
2007-12-13 |
2010-11-24 |
Nxp股份有限公司 |
对生物微粒进行测序的生物传感器装置和方法
|
EP3699291A1
(de)
|
2008-01-17 |
2020-08-26 |
Sequenom, Inc. |
Einzelmolekülnukleinsäurensequenzanalyseverfahren und zusammensetzungen
|
AU2009205956B2
(en)
|
2008-01-18 |
2015-07-02 |
President And Fellows Of Harvard College |
Methods of detecting signatures of disease or conditions in bodily fluids
|
US20110097704A1
(en)
*
|
2008-01-29 |
2011-04-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of picornaviruses
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
EP2271772B1
(de)
|
2008-03-11 |
2014-07-16 |
Sequenom, Inc. |
Tests auf nukleinsäurebasis zur pränatalen geschlechtsbestimmung
|
US8206926B2
(en)
|
2008-03-26 |
2012-06-26 |
Sequenom, Inc. |
Restriction endonuclease enhanced polymorphic sequence detection
|
CA2991818C
(en)
|
2008-03-28 |
2022-10-11 |
Pacific Biosciences Of California, Inc. |
Compositions and methods for nucleic acid sequencing
|
ES2708826T3
(es)
|
2008-05-02 |
2019-04-11 |
Orig3N Inc |
Detección de la predisposición genética a afecciones asociadas a la osteoartritis
|
DK2291543T3
(en)
|
2008-05-16 |
2015-06-01 |
Interleukin Genetics Inc |
GENETIC MARKERS FOR WEIGHT CONTROL AND methods of use thereof
|
WO2009155103A2
(en)
*
|
2008-05-30 |
2009-12-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of tick-borne pathogens
|
US20110177515A1
(en)
*
|
2008-05-30 |
2011-07-21 |
Ibis Biosciences, Inc. |
Compositions for use in identification of francisella
|
US20110151437A1
(en)
*
|
2008-06-02 |
2011-06-23 |
Ibis Biosciences, Inc. |
Compositions for use in identification of adventitious viruses
|
EP2310525B1
(de)
|
2008-07-09 |
2014-02-26 |
Celera Corporation |
Mit herz-kreislauf-erkrankungen assoziierte genetische polymorphismen, nachweisverfahren und ihre verwendung
|
EP2316030B1
(de)
|
2008-07-25 |
2019-08-21 |
Wagner, Richard W. |
Proteinscreeningverfahren
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8148163B2
(en)
|
2008-09-16 |
2012-04-03 |
Ibis Biosciences, Inc. |
Sample processing units, systems, and related methods
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
AU2009293232B2
(en)
|
2008-09-16 |
2015-05-14 |
Sequenom Center For Molecular Medicine |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
WO2010033599A2
(en)
|
2008-09-16 |
2010-03-25 |
Ibis Biosciences, Inc. |
Mixing cartridges, mixing stations, and related kits, systems, and methods
|
US8534447B2
(en)
|
2008-09-16 |
2013-09-17 |
Ibis Biosciences, Inc. |
Microplate handling systems and related computer program products and methods
|
WO2010039755A1
(en)
*
|
2008-10-02 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of members of the bacterial genus mycoplasma
|
WO2010039696A1
(en)
*
|
2008-10-02 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of herpesviruses
|
US20110183343A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Rangarajan Sampath |
Compositions for use in identification of members of the bacterial class alphaproteobacter
|
US20110183345A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of streptococcus pneumoniae
|
WO2010039787A1
(en)
*
|
2008-10-03 |
2010-04-08 |
Ibis Biosciences, Inc. |
Compositions for use in identification of clostridium difficile
|
US20110190170A1
(en)
*
|
2008-10-03 |
2011-08-04 |
Ibis Biosciences, Inc. |
Compositions for use in identification of antibiotic-resistant bacteria
|
US20110183346A1
(en)
*
|
2008-10-03 |
2011-07-28 |
Ibis Biosciences, Inc. |
Compositions for use in identification of neisseria, chlamydia, and/or chlamydophila bacteria
|
CA2741592A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Abbott Laboratories |
Diagnostic test for mutations in codons 12-13 of human k-ras
|
WO2010080616A1
(en)
|
2008-12-19 |
2010-07-15 |
Abbott Laboratories |
Molecular assay for diagnosis of malaria
|
US20120028254A1
(en)
|
2009-02-06 |
2012-02-02 |
Weidhaas Joanne B |
SNP Marker of Breast and Ovarian Cancer Risk
|
EP2394175B1
(de)
*
|
2009-02-09 |
2016-02-03 |
caprotec bioanalytics GmbH |
Vorrichtungen, systeme und verfahren zur trennung magnetischer partikel
|
EP3722810A3
(de)
|
2009-02-11 |
2021-01-13 |
Caris MPI, Inc. |
Molekulare profilierung von tumoren
|
EP2396803A4
(de)
|
2009-02-12 |
2016-10-26 |
Ibis Biosciences Inc |
Ionisationssondenanordnungen
|
WO2010104798A1
(en)
|
2009-03-08 |
2010-09-16 |
Ibis Biosciences, Inc. |
Bioagent detection methods
|
CA2755615A1
(en)
*
|
2009-03-18 |
2010-09-23 |
Sequenom, Inc. |
Use of thermostable endonucleases for generating reporter molecules
|
US9393564B2
(en)
|
2009-03-30 |
2016-07-19 |
Ibis Biosciences, Inc. |
Bioagent detection systems, devices, and methods
|
EP2414545B1
(de)
|
2009-04-03 |
2017-01-11 |
Sequenom, Inc. |
Zusammensetzungen und verfahren für die herstellung von nukleinsäuren
|
WO2010123625A1
(en)
|
2009-04-24 |
2010-10-28 |
University Of Southern California |
Cd133 polymorphisms predict clinical outcome in patients with cancer
|
US20110171619A1
(en)
*
|
2009-05-28 |
2011-07-14 |
Daniel Leo Sweeney |
Representation of molecules as sets of masses of complementary subgroups and contiguous complementary subgroups
|
EP2261242A1
(de)
|
2009-06-10 |
2010-12-15 |
Universite Catholique De Louvain |
Aspartat-N-Acetyltransferaseenzym, Diagnoseverfahren und therapeutisches Verfahren
|
AU2010265889A1
(en)
|
2009-06-25 |
2012-01-19 |
Yale University |
Single nucleotide polymorphisms in BRCA1 and cancer risk
|
WO2011004345A1
(en)
|
2009-07-09 |
2011-01-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Upstream binding protein 1 polymorphisms and their use for prognosing or diagnosing arterial blood pressure
|
US8950604B2
(en)
|
2009-07-17 |
2015-02-10 |
Ibis Biosciences, Inc. |
Lift and mount apparatus
|
EP2454000A4
(de)
|
2009-07-17 |
2016-08-10 |
Ibis Biosciences Inc |
Systeme zur identifizierung von biowirkstoffen
|
WO2011014811A1
(en)
|
2009-07-31 |
2011-02-03 |
Ibis Biosciences, Inc. |
Capture primers and capture sequence linked solid supports for molecular diagnostic tests
|
US9080209B2
(en)
|
2009-08-06 |
2015-07-14 |
Ibis Biosciences, Inc. |
Non-mass determined base compositions for nucleic acid detection
|
US20110065111A1
(en)
*
|
2009-08-31 |
2011-03-17 |
Ibis Biosciences, Inc. |
Compositions For Use In Genotyping Of Klebsiella Pneumoniae
|
EP2957641B1
(de)
|
2009-10-15 |
2017-05-17 |
Ibis Biosciences, Inc. |
Multiple-displacement-amplifikation
|
WO2011056688A2
(en)
|
2009-10-27 |
2011-05-12 |
Caris Life Sciences, Inc. |
Molecular profiling for personalized medicine
|
US20120316187A1
(en)
|
2009-11-13 |
2012-12-13 |
Pangaea Biotech, S.L. |
Molecular biomarkers for predicting response to tyrosine kinase inhibitors in lung cancer
|
EP2499159B1
(de)
|
2009-11-13 |
2017-01-04 |
Dana-Farber Cancer Institute, Inc. |
Zusammensetzungen, kits und verfahren zur diagnose, prognose, überwachung, behandlung und modulierung von auf transplantationen folgenden lymphoproliferativen erkrankungen und hypoxievermittelten angiogeneseerkrankungen mithilfe von galectin-1
|
WO2011084757A1
(en)
|
2009-12-21 |
2011-07-14 |
University Of Southern California |
Germline polymorphisms in the sparc gene associated with clinical outcome in gastric cancer
|
WO2011087760A2
(en)
|
2009-12-22 |
2011-07-21 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
WO2011085334A1
(en)
|
2010-01-11 |
2011-07-14 |
University Of Southern California |
Cd44 polymorphisms predict clinical outcome in patients with gastric cancer
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
US20120014956A1
(en)
|
2010-02-02 |
2012-01-19 |
Hartmut Kupper |
Methods and compositions for predicting responsiveness to treatment with tnf-alpha inhibitor
|
TWI518325B
(zh)
|
2010-02-04 |
2016-01-21 |
自治醫科大學 |
對alk抑制劑具有先抗性或後抗性癌症的識別、判斷和治療
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
US9758840B2
(en)
|
2010-03-14 |
2017-09-12 |
Ibis Biosciences, Inc. |
Parasite detection via endosymbiont detection
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
US9738938B2
(en)
|
2010-05-07 |
2017-08-22 |
Medical Diagnostic Laboratories, Llc |
Single nucleotide polymorphisms and community-associated methicillin-resistant Staphylococcus aureus
|
CA2802964C
(en)
|
2010-06-23 |
2021-08-31 |
Deutsches Krebsforschungszentrum |
Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
|
DK2399928T3
(da)
|
2010-06-23 |
2018-01-29 |
Deutsches Krebsforsch |
Specifikke TT-virus-sekvenser og kimæriske TT-virusværtscelle-DNA-molekyler til anvendelse ved diagnosticering, forebyggelse og behandling af cancer og auto-immunitet
|
US20120053073A1
(en)
|
2010-07-23 |
2012-03-01 |
President And Fellows Of Harvard College |
Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
|
EP2596116A4
(de)
|
2010-07-23 |
2014-03-19 |
Harvard College |
Verfahren zur erkennung von autoimmun- oder autoimmunbezogenen erkrankungen oder leiden
|
WO2012012717A1
(en)
|
2010-07-23 |
2012-01-26 |
President And Fellows Of Harvard College |
Methods of detecting prenatal or pregnancy-related diseases or conditions
|
WO2012039964A1
(en)
|
2010-09-24 |
2012-03-29 |
Wisconsin Alumni Research Foundation |
Compositions and methods for predicting hcv susceptibility to antiviral agents
|
WO2012051301A1
(en)
|
2010-10-12 |
2012-04-19 |
President And Fellows Of Harvard College |
Methods for identifying modulators of triglyceride metabolism, for modulating triglyceride metabolism and for identifying subjects at risk for abnormal triglyceride metabolism
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
SG10201701933XA
(en)
|
2010-11-05 |
2017-05-30 |
Morphotek Inc |
Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers
|
EP2655607A4
(de)
|
2010-12-21 |
2014-05-14 |
Univ North Carolina |
Verfahren und zusammensetzungen zur herstellung aktiver vitamin-k-abhängiger proteine
|
US9956236B2
(en)
|
2011-02-07 |
2018-05-01 |
Cornell University |
Methods for increasing immune responses using agents that directly bind to and activate IRE-1
|
WO2012112883A1
(en)
|
2011-02-18 |
2012-08-23 |
Yale University |
The kras-variant and endometriosis
|
EP2492688A1
(de)
|
2011-02-23 |
2012-08-29 |
Pangaea Biotech, S.A. |
Molekulare Biomarker zur Vorhersage der Reaktion auf die Antitumorbehandlung bei Lungenkrebs
|
CN103501859B
(zh)
|
2011-03-02 |
2017-08-25 |
博格有限责任公司 |
基于细胞的探询式分析及其应用
|
EP2686441B1
(de)
|
2011-03-18 |
2019-05-08 |
Eisai R&D Management Co., Ltd. |
Verfahren und verwendungen zur vorhersage der reaktion auf eribulin
|
US20140065615A1
(en)
|
2011-03-21 |
2014-03-06 |
Yale University |
The KRAS Variant and Tumor Biology
|
EP3378954B1
(de)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantifizierung einer minderheitsvariante einer nukleinsäure
|
CA2835942C
(en)
|
2011-05-19 |
2019-01-22 |
Sequenom, Inc. |
Products and processes for multiplex nucleic acid identification
|
WO2012174419A2
(en)
|
2011-06-17 |
2012-12-20 |
Dana-Farber Cancer Institute, Inc. |
Signatures for predicting the survivability of myelodysplastic syndrome subjects
|
DK2748192T3
(en)
|
2011-08-23 |
2019-02-25 |
Found Medicine Inc |
KIF5B-RET-FUSION MOLECULES AND APPLICATIONS THEREOF
|
WO2013043554A1
(en)
|
2011-09-23 |
2013-03-28 |
Access Business Group International Llc |
Methods for creating recommended dietary regime
|
WO2013055911A1
(en)
|
2011-10-14 |
2013-04-18 |
Dana-Farber Cancer Institute, Inc. |
Znf365/zfp365 biomarker predictive of anti-cancer response
|
KR102043077B1
(ko)
|
2011-10-20 |
2019-11-11 |
노파르티스 아게 |
알파 7 니코틴성 아세틸콜린 수용체 활성화제 치료에 대한 반응성을 예측하는 바이오마커
|
EP2786156A2
(de)
|
2011-11-30 |
2014-10-08 |
AbbVie Deutschland GmbH & Co KG |
Verfahren und zusammensetzungen zur bestimmung des ansprechens auf eine behandlung mit einem tnf-alpha-hemmer
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
SI2814842T1
(sl)
|
2012-02-15 |
2018-10-30 |
Novo Nordisk A/S |
Protitelesa, ki vežejo peptidoglikal prepoznan protein 1
|
PT2814844T
(pt)
|
2012-02-15 |
2017-09-18 |
Novo Nordisk As |
Anticorpos que se ligam e bloqueiam recetor de acionamento expresso em células mieloides-1 (trem-1)
|
EP4155401A1
(de)
|
2012-03-02 |
2023-03-29 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
KR20200105524A
(ko)
|
2012-04-02 |
2020-09-07 |
버그 엘엘씨 |
조사적 세포 기반 분석 및 이의 사용
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
EP2858648B1
(de)
|
2012-06-07 |
2018-08-22 |
Beth Israel Deaconess Medical Center, Inc. |
Verfahren und zusammensetzungen zur pin1-hemmung
|
US20140004105A1
(en)
|
2012-06-29 |
2014-01-02 |
Sequenom, Inc. |
Age-related macular degeneration diagnostics
|
CA2878979C
(en)
|
2012-07-13 |
2021-09-14 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
EP3354750A1
(de)
|
2012-07-18 |
2018-08-01 |
Siemens Healthcare Diagnostics Inc. |
Kit zur normalisierung von biologischen proben
|
WO2014022830A2
(en)
|
2012-08-03 |
2014-02-06 |
Foundation Medicine, Inc. |
Human papilloma virus as predictor of cancer prognosis
|
EP2904534B1
(de)
|
2012-10-04 |
2021-12-15 |
Sequenom, Inc. |
Verfahren und prozesse zur nichtinvasiven beurteilung genetischer variationen
|
CA2889765C
(en)
|
2012-10-26 |
2021-06-22 |
Minna D. BALBAS |
Androgen receptor variants and methods for making and using
|
US10260089B2
(en)
|
2012-10-29 |
2019-04-16 |
The Research Foundation Of The State University Of New York |
Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
|
CA2890207A1
(en)
|
2012-11-05 |
2014-05-08 |
Foundation Medicine, Inc. |
Novel ntrk1 fusion molecules and uses thereof
|
WO2014091388A2
(en)
|
2012-12-11 |
2014-06-19 |
Novartis Ag |
Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
|
CA3150658A1
(en)
|
2013-01-18 |
2014-07-24 |
Foundation Medicine, Inc. |
Methods of treating cholangiocarcinoma
|
US9896728B2
(en)
|
2013-01-29 |
2018-02-20 |
Arcticrx Ltd. |
Method for determining a therapeutic approach for the treatment of age-related macular degeneration (AMD)
|
US11585814B2
(en)
|
2013-03-09 |
2023-02-21 |
Immunis.Ai, Inc. |
Methods of detecting prostate cancer
|
NZ771629A
(en)
|
2013-03-09 |
2022-12-23 |
Harry Stylli |
Methods of detecting cancer
|
WO2014168711A1
(en)
|
2013-03-13 |
2014-10-16 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
EP2805769A1
(de)
|
2013-05-24 |
2014-11-26 |
European Molecular Biology Laboratory |
Verfahren zur nanoskaligen Einzelzellenanalyse
|
US20160122829A1
(en)
|
2013-06-06 |
2016-05-05 |
Dana-Farber Cancer Institute, Inc. |
Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Cancer Using PD-L1 Isoforms
|
WO2014201155A1
(en)
|
2013-06-11 |
2014-12-18 |
Courtagen Life Sciences, Inc. |
Methods and kits for treating and classifying individuals at risk of or suffering from trap1 change-of-function
|
AU2014290044B2
(en)
|
2013-07-17 |
2020-10-29 |
Foundation Medicine, Inc. |
Methods of treating urothelial carcinomas
|
US20160175401A1
(en)
|
2013-07-31 |
2016-06-23 |
Dana-Farber Cancer Institute Inc. |
Compoitions and methods for modulating thermogenesis using pth-related and egf-related compounds
|
DK3049521T3
(en)
|
2013-09-25 |
2019-04-23 |
Univ Cornell |
Compounds for inducing antitumor immunity and methods thereof
|
EP2868751A1
(de)
|
2013-10-30 |
2015-05-06 |
Deutsches Krebsforschungszentrum |
HCBI-Sequenzen als früher Marker für die zukünftige Entwicklung von Krebs und Erkrankungen des zentralen Nervensystems, und als Ziel zur Behandlung und Prävention von Krebs
|
WO2015120130A1
(en)
|
2014-02-07 |
2015-08-13 |
Novartis Ag |
Impact of genetic factors on disease progression and response to anti-c5 antibody in geographic atrophy
|
EP3117011B1
(de)
|
2014-03-13 |
2020-05-06 |
Sequenom, Inc. |
Verfahren und prozesse zur nicht-invasiven beurteilung genetischer variationen
|
US11624093B2
(en)
|
2014-04-24 |
2023-04-11 |
Dana-Farber Cancer Institute, Inc. |
Tumor suppressor and oncogene biomarkers predictive of anti-immune checkpoint inhibitor response
|
CN106413750B
(zh)
|
2014-05-16 |
2022-04-29 |
免疫医疗有限责任公司 |
具有增强的治疗和诊断特性的带有改变的新生儿Fc受体结合的分子
|
EP2966176A1
(de)
|
2014-07-10 |
2016-01-13 |
Deutsches Krebsforschungszentrum |
HCBIO-, MSBI-, MSSI- und CMI-Sequenzen als frühe Marker für die zukünftige Entwicklung von Krebs und Erkrankungen des ZNS und als Ziel zur Behandlung und Prävention dieser Erkrankungen
|
MY178347A
(en)
|
2014-07-17 |
2020-10-08 |
Novo Nordisk As |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity
|
WO2016011265A2
(en)
|
2014-07-17 |
2016-01-21 |
Beth Israel Deaconess Medical Center, Inc. |
Biomarkers for pin1-associated disorders
|
EP3693742B1
(de)
|
2014-09-11 |
2022-04-06 |
Harry Stylli |
Verfahren zum nachweis von prostatakrebs
|
AU2015328411C1
(en)
|
2014-10-06 |
2022-03-03 |
Dana-Farber Cancer Institute, Inc. |
Angiopoietin-2 biomarkers predictive of anti-immune checkpoint response
|
US10806773B2
(en)
|
2014-10-09 |
2020-10-20 |
Dana-Farber Cancer Institute, Inc. |
Multiple-variable IL-2 dose regimen for treating immune disorders
|
EP3265825A4
(de)
|
2015-03-06 |
2018-08-08 |
Dana-Farber Cancer Institute, Inc. |
Pd-l2-biomarker zur vorhersage von pd-1-weg-inhibitor-reaktionen bei ösophagogastrischem krebs
|
WO2016145186A1
(en)
|
2015-03-12 |
2016-09-15 |
Beth Israel Deaconess Medical Center, Inc. |
Enhanced atra-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
|
CN107787371B
(zh)
|
2015-04-24 |
2022-02-01 |
基纳生物技术有限公司 |
检测和定量次要变体的并行式方法
|
AU2016250841A1
(en)
|
2015-04-24 |
2017-11-02 |
Agena Bioscience, Inc. |
Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
|
AU2016257772B2
(en)
|
2015-05-01 |
2022-06-02 |
Griffith University |
Diagnostic methods
|
WO2017075329A2
(en)
|
2015-10-29 |
2017-05-04 |
Dana-Farber Cancer Institute, Inc. |
Methods for identification, assessment, prevention, and treatment of metabolic disorders using pm20d1 and n-lipidated amino acids
|
US10894985B2
(en)
|
2016-01-12 |
2021-01-19 |
Sitokine Limited |
Methods for predicting response to treatment
|
CN109476731A
(zh)
|
2016-02-29 |
2019-03-15 |
基础医药有限公司 |
治疗癌症的方法
|
CN109790581A
(zh)
|
2016-04-27 |
2019-05-21 |
米拉迪克斯有限公司 |
Kras-变体癌症患者的基于免疫的治疗
|
US11471462B2
(en)
|
2016-06-27 |
2022-10-18 |
The Broad Institute, Inc. |
Compositions and methods for detecting and treating diabetes
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
WO2018045162A1
(en)
|
2016-09-01 |
2018-03-08 |
Biogen Ma Inc. |
Biomarkers predictive of primary progressive multiple sclerosis and uses thereof
|
JP7466308B2
(ja)
|
2016-09-20 |
2024-04-12 |
デイナ ファーバー キャンサー インスティチュート,インコーポレイテッド |
Usp10バイオマーカーおよびモジュレーターを用いたamlの同定、評価、予防および処置のための組成物および方法
|
US10329620B2
(en)
|
2017-01-12 |
2019-06-25 |
Cardioforecast Ltd. |
Methods and kits for treating cardiovascular disease
|
WO2018132639A1
(en)
|
2017-01-13 |
2018-07-19 |
Foster Charles Stephen |
Methods and kits for the diagnosis and/or prognosis of ocular cicatricial pemphigoid
|
WO2018226685A2
(en)
|
2017-06-06 |
2018-12-13 |
Dana-Farber Cancer Institute, Inc. |
Methods for sensitizing cancer cells to t cell-mediated killing by modulating molecular pathways
|
US20200341004A1
(en)
*
|
2017-10-27 |
2020-10-29 |
Frontier Diagnostics, Llc |
Mass spectrometry methods for carcinoma assessments
|
US11851679B2
(en)
|
2017-11-01 |
2023-12-26 |
Juno Therapeutics, Inc. |
Method of assessing activity of recombinant antigen receptors
|
US11155618B2
(en)
|
2018-04-02 |
2021-10-26 |
Bristol-Myers Squibb Company |
Anti-TREM-1 antibodies and uses thereof
|
WO2019232460A1
(en)
|
2018-06-01 |
2019-12-05 |
Agena Bioscience, Inc. |
Products and processes for nucleic acid detection and quantification
|
CA3107467A1
(en)
|
2018-09-07 |
2020-03-12 |
Sequenom, Inc. |
Methods, and systems to detect transplant rejection
|
KR20210111254A
(ko)
|
2018-11-30 |
2021-09-10 |
캐리스 엠피아이, 아이엔씨. |
차세대 분자 프로파일링
|
EP3686289A1
(de)
|
2019-01-24 |
2020-07-29 |
Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts |
Cmi-sequenzen als frühmarker für die zukünftige entwicklung von krebs, atherosklerose, diabetes und erkrankungen des zns und als ziel für die behandlung und prävention dieser erkrankungen
|
CA3128894A1
(en)
|
2019-02-19 |
2020-08-27 |
Sequenom, Inc. |
Compositions, methods, and systems to detect hematopoietic stem cell transplantation status
|
US20220249660A1
(en)
|
2019-06-06 |
2022-08-11 |
Sitokine Limited |
Compositions and methods for treating lung, colorectal and breast cancer
|
WO2021028469A1
(en)
|
2019-08-12 |
2021-02-18 |
Sitokine Limited |
Compositions and methods for treating cytokine release syndrome and neurotoxicity
|
WO2021112918A1
(en)
|
2019-12-02 |
2021-06-10 |
Caris Mpi, Inc. |
Pan-cancer platinum response predictor
|
US20230120825A1
(en)
|
2020-02-28 |
2023-04-20 |
Laboratory Corporation Of America Holdings |
Compositions, Methods, and Systems for Paternity Determination
|
WO2021205013A1
(en)
|
2020-04-09 |
2021-10-14 |
Sitokine Limited |
Compositions and methods for treating covid-19
|
KR20230165212A
(ko)
|
2021-03-02 |
2023-12-05 |
다나-파버 캔서 인스티튜트 인크. |
적혈구 장애의 치료 방법
|
WO2022261183A2
(en)
|
2021-06-08 |
2022-12-15 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating and/or identifying an agent for treating intestinal cancers
|
CN113980050B
(zh)
*
|
2021-10-25 |
2023-07-28 |
中元汇吉生物技术股份有限公司 |
一种修饰的核苷酸,组合物及试剂
|
WO2023097119A2
(en)
|
2021-11-29 |
2023-06-01 |
Dana-Farber Cancer Institute, Inc. |
Methods and compositions to modulate riok2
|
WO2023158732A1
(en)
|
2022-02-16 |
2023-08-24 |
Dana-Farber Cancer Institute, Inc. |
Methods for decreasing pathologic alpha-synuclein using agents that modulate fndc5 or biologically active fragments thereof
|
US20230357446A1
(en)
|
2022-04-11 |
2023-11-09 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for universal tumor cell killing
|
GB202208171D0
(en)
|
2022-06-01 |
2022-07-13 |
Institute Of Cancer Res |
Method
|